Tsang Featured in The Pink Sheet on Post-Brexit Pharmaceutical Regulations

Life Sciences and Healthcare Regulatory partner Lincoln Tsang was featured in a recent The Pink Sheet article, "Pharma Firms Urged To Push For Post-Brexit Regulatory Equivalence Deal," which examines the ramifications of a post-Brexit regulatory equivalence agreement between the UK and EU on the pharmaceutical industry.

» Read the full article (subscription required).